Medtronic (MDT) Offering Possible 33.69% Return Over the Next 20 Calendar Days

view original post

Medtronic’s most recent trend suggests a bearish bias. One trading opportunity on Medtronic is a Bear Call Spread using a strike $123.00 short call and a strike $128.00 long call offers a potential 33.69% return on risk over the next 20 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $123.00 by expiration. The full premium credit of $1.26 would be kept by the premium seller. The risk of $3.74 would be incurred if the stock rose above the $128.00 long call strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Medtronic is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for Medtronic is bearish.

The RSI indicator is at 40.96 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Medtronic

Engineering Impact: Inclusion, Diversity & Equity
Thu, 28 Oct 2021 21:56:06 +0000
Excerpts from the 2021 Medtronic Integrated Performance Report

Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
Thu, 28 Oct 2021 21:50:09 +0000
In the latest trading session, Medtronic (MDT) closed at $121.27, marking a -1% move from the previous day.

Medtronic To Face Class Action Suit From Canadian Users Of MiniMed Insulin Pumps
Thu, 28 Oct 2021 19:59:53 +0000
A national class action in Canada has been commenced against Medtronic Plc (NYSE: MDT) over its MiniMed 630G and 670G insulin pumps. Rochon Genova and Cardill Law commenced the proposed class-action suit against Medtronic, Medtronic MiniMed, and Medtronic of Canada over the insulin pumps approved in Canada in 2016 and 2018. Related Link: Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps. For the same issue, missing or broken retainer rings that could result in the over-or under-delive

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Thu, 28 Oct 2021 14:22:13 +0000
In this article we are going to estimate the intrinsic value of Medtronic plc ( NYSE:MDT ) by projecting its future…

The Zacks Analyst Blog Highlights: Disney, Intel, Medtronic, Target and Deere
Wed, 27 Oct 2021 10:57:10 +0000
The Zacks Analyst Blog Highlights: Disney, Intel, Medtronic, Target and Deere

Be Sociable, Share!

Related Posts